Status
Conditions
Treatments
About
In this study, the investigators will collect data on patients who are using the Aspira system as part of their clinical care for the management of recurrent pleural effusion. Data will be collected on patient demographics, placement of the pleural catheter, palliation of dyspnea, complication rates, and rates of spontaneous pleurodesis.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Male or female, at least 18 years of age, inclusive
Subject has a symptomatic malignant pleural effusion requiring intervention. For an effusion to be defined as malignant, at least one of the following must be true
Subject is able to provide informed consent
Subject has sufficient pleural fluid to allow safe insertion of an indwelling tunneled pleural catheter as determined by the PI
Subject is able to perform home drainage of the pleural effusion or has sufficient resources (family member, caregiver, home health).
Exclusion criteria
40 participants in 1 patient group
Loading...
Central trial contact
Alexander Chen, M.D.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal